What is Transcatheter Heart Valve Replacement and Repair?
Transcatheter heart valve replacement is a minimally invasive technique that replaces a constricted or failing aortic valve (aortic valve stenosis). Transcatheter heart valve implantation is another name for transcatheter heart valve replacement. For those who are at intermediate or high risk of problems from surgical aortic valve replacement (open-heart surgery), TAVR may be advisable treatment. Growing number of heart related chronic diseases as well as increasing geriatrics population are significant reasons for the growth of the transcatheter heart valve replacement and repair market. High costs or lack of skilled professionals in certain regions may be limiting factor for the growth of the market. Currently, the North American region is the leading market.
The market study is broken down by Type (Transcatheter Aortic Valve Replacement, Transcatheter Mitral Valve Repair and Replacement and Transcatheter Pulmonary Valve Replacement) and major geographies with country level break-up.
Changing urban lifestyle and drastic changes in the environment has led to growing number of heart related chronic diseases. Similarly, the growing number of geriatrics population too has been significant towards exponential rise of transcatheter heart valve replacement and repair market. Medical insurance and government subsidies can be primary towards providing comprehensive treatment to every required person. North America is the leading market of transcatheter heart valve replacement and repair market. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Abbott Laboratories (United States), Boston Scientific Corporation (United States), Medtronic Plc (Ireland), Braile Biomedica (Brazil), St. Jude Medical, Inc. (United States), Edwards Lifesciences (United States), CryoLife, Inc. (United States), Neovasc Inc. (Canada), JenaValve Technology (United States) and LivaNova, Plc (United Kingdom) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are HeartWare International Inc. (United States), MiCardia Corporation (United States) and HighLife Medical (France).
AdvanceMarketAnalytics has segmented the market of Global Transcatheter Heart Valve Replacement and Repair market by Type, Application and Region.
On the basis of geography, the market of Transcatheter Heart Valve Replacement and Repair has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Disease Type, the sub-segment i.e. Aortic Valvular Heart Disease will boost the Transcatheter Heart Valve Replacement and Repair market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End Use, the sub-segment i.e. Hospitals will boost the Transcatheter Heart Valve Replacement and Repair market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Leaders and their expansionary development strategies
In 2019, Venus Medtech (Hangzhou) Inc., a China based leading transcatheter heart valve medical device manufacturer and seller has announced acquisition of Keystone Heart Ltd., which is an Israel based medical device company specialised in the production of Cerebral Embolic Protection Devices such as TriGUARD 3. The acquisition deal would enable Venus Medtech to lower the danger of brain injury during cardiac surgeries, but also build a foothold in the US and EMEA, allowing us to present our whole product line.
In 2020, Medtronic plc, an American-Irish registered medical device company has announced a partnership with The Foundry, a medical device company incubator. The partnership would be aimed at combining Medtronic's expertise in Structural Heart with The Foundry's innovations in transcatheter mitral valve repair and replacement.
- Transcatheter Mitral Valve Repair and Replacement Accounts for Largest Market Share
- Rising Number of Chronic Diseases Related to Heart
- Increase in Geriatrics Population
- Asia Pacific Market is expected to Present Huge Opportunity to Expand due to Presence of Emerging Economies in the Region
- High Cost of the Treatment
- Lack of Skilled Medical Professionals or Required Medical Infrastructure in Developing Countries
Key Target AudienceTranscatheter Heart Valve Replacement and Repair Providers, New Entrants/Investors, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End-Use Industries
About ApproachTo evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand companys positioning regarding market value, volume and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.
Frequently Asked Questions (FAQ):
1. What all players are profiled in the study?
The standard version of the report profiles players such as Abbott Laboratories (United States), Boston Scientific Corporation (United States), Medtronic Plc (Ireland), Braile Biomedica (Brazil), St. Jude Medical, Inc. (United States), Edwards Lifesciences (United States), CryoLife, Inc. (United States), Neovasc Inc. (Canada), JenaValve Technology (United States) and LivaNova, Plc (United Kingdom) etc.
2. Can we have customized study for Transcatheter Heart Valve Replacement and Repair Market?
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
3. What would be the Market Size of Transcatheter Heart Valve Replacement and Repair Market by 2026?
Analysts at AMA estimates Transcatheter Heart Valve Replacement and Repair Market to reach USD Million by 2026.